Status:
TERMINATED
A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain
Lead Sponsor:
Pfizer
Conditions:
Pain, Post Surgical
Eligibility:
All Genders
21-65 years
Phase:
PHASE4
Brief Summary
The objectives of this study were to assess the analgesic efficacy and safety of parecoxib/valdecoxib on post-laparoscopic surgery analgesia.
Detailed Description
This study A3471107 was terminated on February 4th, 2005 due to enrollment difficulties, problems related to need for rescue medication, and perceptions about cardiovascular risk potentially associate...
Eligibility Criteria
Inclusion
- Patients who had undergone laparoscopic surgery
- Patients in need of post-surgical analgesia
Exclusion
- Patients with an unexpected surgical complication which, in the Investigator's opinion, placed the patient at significantly higher risk for post-surgical complication(s), or for non-routine post-operative care requirements
- Patients who took any nonsteroidal anti-inflammatory drug or any analgesic within 48 hours prior to surgery
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00660855
Start Date
June 1 2004
End Date
July 1 2004
Last Update
April 22 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Buenos Aires, Argentina, C1230AAW
2
Pfizer Investigational Site
Buenos Aires, Argentina, C1280AEB